JPH0262811A - Skin cosmetic - Google Patents

Skin cosmetic

Info

Publication number
JPH0262811A
JPH0262811A JP21314588A JP21314588A JPH0262811A JP H0262811 A JPH0262811 A JP H0262811A JP 21314588 A JP21314588 A JP 21314588A JP 21314588 A JP21314588 A JP 21314588A JP H0262811 A JPH0262811 A JP H0262811A
Authority
JP
Japan
Prior art keywords
skin
cream
far
cosmetic
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21314588A
Other languages
Japanese (ja)
Inventor
Kenji Mori
憲治 森
Tatsu Miyamoto
達 宮本
Akira Tsugita
次田 章
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP21314588A priority Critical patent/JPH0262811A/en
Publication of JPH0262811A publication Critical patent/JPH0262811A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To provide a skin cosmetic containing a far IR light-irradiating ceramics and a succinate salt, accelerating the moisture-holding function of a skin, retaining or recovering the skin in a healthy state and exhibiting an excellent skin-beautifying effect. CONSTITUTION:A far IR light-irradiating ceramic powder having an electromagnetic wave-irradiation percent of >=80% based on the electromagnetic irradiation amount of a black body at the same temperature in a wavelength range of 6-20mum and a succinate salt as active ingredients are suitably compounded with a dyestuff, perfume, antiseptic, surfactant, antioxidizing agent, oily base, etc., by a conventional method to provided the objective cosmetic. The contents of the far IR light-irradiating ceramic powder and the succinate salt are 0.01-20wt.% and 0.1-5wt.%, respectively. The cosmetic can be applied to calamine lotions, creams, milky lotions, make-up bases, etc.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、遠赤外線放射性セラミックスとコハク酸の塩
とを含有してなる皮膚の水分保持機能を冗進し得る皮膚
化粧料に関する。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a skin cosmetic that can enhance the moisture retention function of the skin and contains far-infrared emitting ceramics and a succinic acid salt.

(従来技術) 従来より、健常な皮膚を保持する為に、皮膚に適度な水
分と油分を与える親水性の皮膚保湿剤と油性の皮膚柔軟
剤とを皮膚化粧料に配合することが行われている。
(Prior art) In order to maintain healthy skin, hydrophilic skin moisturizers and oily skin softeners that provide appropriate moisture and oil to the skin have traditionally been blended into skin cosmetics. There is.

皮膚保温剤には、グリセリン、プロピレングリコール、
ポリエチレングリコール、とロリドンカルボン酸塩等が
利用されているが、これらは、皮膚の最外層である角質
層の水分を吸水して、かえって皮膚の水分を1員失する
原因となることがあり、また、多量に含有する皮膚化粧
料にあっては、べたつくなどの違和感を与えるなど、必
ずしも満足出来るものではなかった。
Skin warming agents include glycerin, propylene glycol,
Polyethylene glycol, lolidone carboxylate, etc. are used, but these may absorb water from the stratum corneum, the outermost layer of the skin, and may actually cause the skin to lose one member of its moisture. Furthermore, skin cosmetics that contain a large amount of such substances are not always satisfactory, as they give an uncomfortable feeling such as stickiness.

また、皮膚柔軟剤には、流動パラフィン、ワセリン、オ
リーブ油、スクアラン、ラノリン、合成エステル油等が
利用されているが、これらも、表皮よりの水分蒸散を充
分に防ぐ程度に皮膚化粧料に含をせしめるときには、皮
膚の正常なる新陳代謝を阻害する原因となるなどの欠点
を有していた。
In addition, liquid paraffin, petrolatum, olive oil, squalane, lanolin, synthetic ester oil, etc. are used as skin softeners, but these are also included in skin cosmetics to the extent that they sufficiently prevent water evaporation from the epidermis. When exposed to skin, it has disadvantages such as inhibiting the normal metabolism of the skin.

(発明の開示) 本発明者等は、皮膚保湿剤、皮膚柔軟剤にみられる上記
の欠点に鑑み、それら配合剤の物理的作用による表皮へ
の水分補給あるいは表皮よりの水分蒸散防止のみに依存
するのではなく、皮膚が本来備えている水分保持機能を
冗進することによって皮膚を健常な状態に保持し、ある
いは修復するような皮膚化粧料を提供することを目的と
して脱核目的に合致する事を見出し本発明を完成した。
(Disclosure of the Invention) In view of the above-mentioned drawbacks of skin moisturizers and emollients, the present inventors have determined that they rely only on the physical action of these ingredients to replenish moisture to the epidermis or prevent water evaporation from the epidermis. The aim is to provide skin cosmetics that maintain or repair the skin in a healthy state by enhancing the skin's inherent moisture retention function, rather than denucleation. They discovered this and completed the present invention.

皮膚の水分は、真皮から表皮の基底細胞層、更に角質層
へと外層に向うにつれて減少する水分含量の勾配に沿っ
て、常に皮膚内部から外層部へ移動し、角質層を通じて
外部へ蒸散しているが、この水分蒸成は主に顆粒層頂部
の層板顆粒から角質層に及び緻密な細胞U織からなる防
御機能(バリヤー機能)により制御されており、該蒸散
量〔不感蒸泄(Transepidermal Wat
er Loss)値(以下、TWI−値という)で表わ
される〕は例えば健常な皮膚の正常な状態における前腕
部皮表では0.2〜0.3mg/cm”/hrの範囲、
通常は0.25mg/cm2/hr程度以下に保持され
ている。
Moisture in the skin constantly moves from the inside of the skin to the outer layer, along a gradient of water content that decreases as it goes from the dermis to the basal cell layer of the epidermis, then to the stratum corneum, and then transpires to the outside through the stratum corneum. However, this water evaporation is mainly controlled by a protective function (barrier function) consisting of a dense cellular U weave extending from the lamellar granules at the top of the granular layer to the stratum corneum. Wat
er Loss) value (hereinafter referred to as TWI value)] is in the range of 0.2 to 0.3 mg/cm''/hr on the skin surface of the forearm in a normal state of healthy skin, for example.
It is usually maintained at about 0.25 mg/cm2/hr or less.

これに対して、通常にみられる乾燥皮膚(ドライスキン
)あるいは老化皮膚にみられる乾燥皮膚では、その程度
に応してTWL値は上記の範囲の上限値もしくはそれよ
り大きな値を示し、皮膚の水分保持機能が低下している
ことが認められる。これはそれら乾燥皮膚の場合、角質
層の防御機能による通常の制御限界を超えた状態にある
か、あるいは該防御機能が衰えていることに由来するも
のである。
On the other hand, in the case of dry skin that is normally observed (dry skin) or dry skin that occurs in aging skin, the TWL value shows the upper limit of the above range or a value higher than that depending on the degree of dry skin, and the It is recognized that the water retention function has decreased. This is because, in the case of dry skin, the normal control limit of the protective function of the stratum corneum is exceeded, or the protective function of the stratum corneum is weakened.

従って、角質層及び層板顆粒の組織を緻密化し、その防
御機能を賦活することができれば、これによって皮膚の
水分保持機能が亢進され、皮膚は健常な状態に保持され
ると共に、更に乾燥皮膚の改善ないしは修復が可能とな
るのである。
Therefore, if we can densify the structure of the stratum corneum and lamellar granules and activate their defense function, this will enhance the moisture retention function of the skin, maintain the skin in a healthy state, and further reduce dry skin. Improvement or repair is possible.

そこで、本発明者等は、コハク酸の塩類の人皮膚に対す
る作用効果に関して鋭意研究した結果、コハク酸の塩類
が皮膚の細胞呼吸を活性化し、顆粒層頂部の層板顆粒か
ら角質層に至る組織を正常より繊密化された皮膚細肪中
の成分が遠赤外によって活性化され、緻密化された皮膚
細胞を増強し、水分保持機能を高め、角質のターンオー
バーを促進し、乾燥皮膚を改善し、あるいは皮膚を健常
な状態に保持してその老化を防ぎ、皮膚に湿潤性(しっ
とり惑)、柔軟性(滑らか感)、弾力性及び艶を与える
美肌効果を有することを見出し本発明を完成するに至っ
た。本発明の皮膚化粧料の場合、従来の皮膚化粧料のご
とく前記の皮膚湿潤剤、皮膚柔軟剤を多量に配合する必
要がなく、皮膚の正常な生理機能が妨げられる虞れがな
い。
Therefore, as a result of intensive research into the effects of succinic acid salts on human skin, the present inventors found that succinic acid salts activate cellular respiration in the skin, leading to tissue formation from the lamellar granules at the top of the granular layer to the stratum corneum. Components in skin fat that are more densified than normal are activated by far infrared rays, strengthening densified skin cells, increasing moisture retention, promoting keratin turnover, and reducing dry skin. The present invention has been found to have a skin beautifying effect that improves the skin and prevents aging by maintaining the skin in a healthy state and imparting moisture (moistness), flexibility (smoothness), elasticity and luster to the skin. It was completed. In the case of the skin cosmetics of the present invention, unlike conventional skin cosmetics, there is no need to incorporate large amounts of the above-mentioned skin moisturizers and skin softeners, and there is no risk of interfering with the normal physiological functions of the skin.

(発明の目的) 本発明の目的は、皮膚が本来備えている水分保持機能を
亢進することによって皮膚を健常な状態に保持し、或い
は修復して、優れた美肌効果を有する皮膚化粧料を提供
するにある。
(Objective of the Invention) The object of the present invention is to provide a skin cosmetic that maintains or repairs the skin in a healthy state by enhancing the skin's inherent moisture retention function and has an excellent skin beautifying effect. There is something to do.

(発明の構成) 本発明は、波長6〜20μmの範囲において、同一温度
の黒体の電磁波放射量を基準としたときの電磁波放射百
分率が80%以上である遠赤外線放射性セラミックス粉
体と、コハク酸の塩とを含有してなる皮膚化粧料である
(Structure of the Invention) The present invention provides a far-infrared emitting ceramic powder having an electromagnetic radiation percentage of 80% or more based on the electromagnetic radiation amount of a black body at the same temperature in the wavelength range of 6 to 20 μm; A skin cosmetic containing an acid salt.

(構成の黒体的な説明) 本発明における電磁波放射百分率とは、一定温度におけ
るエネルギー放射量がブランクの法則に従う理想黒体の
エネルギー放射強度を100%とした時の、試料の同一
温度における相対エネルギー放射率の事である。試料の
電磁波放射百分率は温度によっては異ならないが、試料
が体温によっ30〜70℃の温度範囲で波長6μm〜2
0μmの電磁波の放射百分率が80%以上のものを使用
する。
(Blackbody explanation of the structure) The electromagnetic radiation percentage in the present invention is the relative radiation intensity of a sample at the same temperature, when the energy radiation intensity of an ideal black body at a constant temperature follows Blank's law is taken as 100%. It is energy emissivity. The electromagnetic radiation percentage of a sample does not vary depending on temperature, but the wavelength of the sample varies from 6 μm to 2 μm in the temperature range of 30 to 70°C depending on body temperature.
A material with a radiation percentage of 0 μm electromagnetic waves of 80% or more is used.

本発明で使用する遠赤外線放射性セラミ・7クス粉体は
公知のマグネシウム酸化物、アルミニウム酸化物、ジル
コニウム酸化物、ケイ素酸化物、あるいは金属の炭酸塩
、粘度t′pA等を例えば下記の化学反応式に示す比率
(化学M論比)で充分均一に混合し、1000°C以上
で焼成、粉砕して得られる。たとえばコージーライト 
(2Mg0・2A1zO3・5SiOz)はタルク (
3Mg0・4SiOz  ・H2O)とカイ!リン(A
ffizO*・2SiOz  ・2HtO)とマグネサ
イト(MgC○、)とを混合し、1400℃で焼成した
ものを粉砕して得られる。化学反応式で示すと次の通り
である。
The far-infrared emissive ceramic/7x powder used in the present invention is made of known magnesium oxide, aluminum oxide, zirconium oxide, silicon oxide, or metal carbonate, viscosity t'pA, etc., by the following chemical reaction. It is obtained by mixing sufficiently uniformly at the ratio shown in the formula (chemical M theoretical ratio), firing at 1000°C or higher, and pulverizing. For example, cozy light
(2Mg0・2A1zO3・5SiOz) is talc (
3Mg0・4SiOz・H2O) and chi! Lin (A
It is obtained by mixing ffizO*・2SiOz・2HtO) and magnesite (MgC○,), firing at 1400°C, and pulverizing the mixture. The chemical reaction formula is as follows.

3Mg0・4 S + Ot  ・Hz O+ 8  
(A 1t O:+−2S io、  ・2H,0) 
+5MgC0* →4(2Mg0・2Al103  ・
55i0.)+17 H20+ 5 COz また、ジルコン(Z r S I Oa )は、ジルコ
ニア(ZrOz)とシリカ(Sift)の混合、焼成、
粉砕によって得られる。又天然に産するジルコン試料を
[3,ruker社製のFT−I Rスペクトロメータ
ーIF5−113V型にて下記の条件で測定する。
3Mg0・4 S + Ot・Hz O+ 8
(A 1t O: +-2S io, ・2H,0)
+5MgC0* →4(2Mg0・2Al103 ・
55i0. )+17 H20+ 5 COz Zircon (Z r S I Oa ) is produced by mixing zirconia (ZrOz) and silica (Sift), firing,
Obtained by grinding. In addition, a naturally occurring zircon sample is measured using an FT-IR spectrometer IF5-113V manufactured by Ruker under the following conditions.

検出器  : DTGS 付属装置 :発光スペクトル測定用付属装置参照試料 
:黒体 測定温度 :60℃ 測定波長 :6〜20μm 尚、上記の放射率は温度によって変わらないので、皮膚
温近辺よりも測定しやすい60℃にて測粉体の内、感触
、効果の点からコニジ−ライト、0.01〜20μmで
ある。20.camよりも大きいと皮膚に異和感を感じ
0.01μmよりも小さいと化粧料中の油性基剤を劣化
される触媒作用が強く放射率曲線は第1図〜第2図に示
す通りで比較の〔分光赤外線放射率曲線の測定法〕 て0.01〜20重量%(以下、wt%と略記する)の
範囲が好適である。0.01 W t%未満では効果が
充分に達成されず、20wt%を越えてもその増加分に
見合った効果の向上は望めない。
Detector: DTGS Attached equipment: Attached equipment reference sample for emission spectrum measurement
:Blackbody measurement temperature: 60℃ Measurement wavelength: 6 to 20μm Note that the above emissivity does not change depending on the temperature, so the feel and effectiveness of the powder measuring body at 60℃, which is easier to measure than near skin temperature. to conidirite, 0.01 to 20 μm. 20. If it is larger than 0.01 μm, it will cause a strange feeling on the skin, and if it is smaller than 0.01 μm, it has a strong catalytic effect that degrades the oil base in cosmetics, and the emissivity curves are compared as shown in Figures 1 and 2. [Method for measuring spectral infrared emissivity curve] A range of 0.01 to 20% by weight (hereinafter abbreviated as wt%) is suitable. If the content is less than 0.01 Wt%, the effect will not be sufficiently achieved, and if it exceeds 20wt%, no improvement in the effect commensurate with the increase can be expected.

本発明に用いるコハク酸の塩は、コハク酸と塩基とから
なるモノ塩またはジ塩であって、例えば、カリウム塩、
ナトリウム塩等のアルカリ金属塩、リジン塩、オルニチ
ン塩、アルギニン塩等の塩基性アミノ酸塩、モノエタノ
ールアミン塩、トリエタノールアミン塩等のアルカノー
ルアミン塩が挙げられる。また、コハク酸の塩としては
、後記の如くその効果に於いて、特にコハク酸と塩基性
アミノ酸塩との塩が好適である。
The succinic acid salt used in the present invention is a monosalt or di-salt consisting of succinic acid and a base, such as potassium salt,
Examples include alkali metal salts such as sodium salts, basic amino acid salts such as lysine salts, ornithine salts, and arginine salts, and alkanolamine salts such as monoethanolamine salts and triethanolamine salts. Further, as the salt of succinic acid, a salt of succinic acid and a basic amino acid salt is particularly suitable in terms of its effects as described later.

コハク酸の塩の含有量は皮膚化粧料#岡錦牛の総量を基
準としてO,1〜5.0 W t%の範囲が好適である
。含有量が0.1 W t%未満では効果が充分に達成
されず、一方s、 o w t%を超えてもその増加分
に見合った効果の向上は望めない。
The content of the succinic acid salt is preferably in the range of 0.1 to 5.0 wt% based on the total amount of skin cosmetic #Oka-Nishikigyu. If the content is less than 0.1 wt%, the effect will not be sufficiently achieved, while if the content exceeds s, o wt%, no improvement in the effect commensurate with the increase can be expected.

本発明の皮膚化粧料は、例えばカラミンローション、ク
リーム類、乳液類、メイクアップベース類等に適用する
ことができる。
The skin cosmetics of the present invention can be applied to, for example, calamine lotions, creams, milky lotions, makeup bases, and the like.

尚、本発明の皮膚化粧料には上記成分の他に色素、香料
、防腐剤、界面活性剤、抗酸化剤、油性基剤等を本発明
の目的を達成する範囲内で適宜配合することができる。
In addition to the above-mentioned ingredients, the skin cosmetics of the present invention may contain pigments, fragrances, preservatives, surfactants, antioxidants, oil bases, etc. as appropriate within the scope of achieving the purpose of the present invention. can.

(実施例) 以下、実施例及び試験例に基づいて本発明を詳説する。(Example) Hereinafter, the present invention will be explained in detail based on Examples and Test Examples.

尚、TWL値、TWL値変化率、角質層ターンオーバー
速度、角質細胞の剥離特性の測定方法或いは評価方法を
下記に示した。
The methods for measuring or evaluating the TWL value, rate of change in TWL value, stratum corneum turnover rate, and exfoliation properties of corneocytes are shown below.

+1)  T W L (直 密閉した皮表上の空気の一定時間内の湿度変化を電気抵
抗にて測定する方法を用いた。
+1) T W L (A method was used to measure the humidity change within a certain period of time in the air above the directly sealed skin surface using electrical resistance.

即ち、被試験者の皮表を測定用セルで密閉し、セルに強
制乾燥した空気を通気してセル内を乾燥空気で充分置換
した後、乾燥空気の通気を停止してその時点でのセル内
の相対湿度RHs  (%)を求め、次いで10分間放
置して再びセル内の相対温度RH,。(%)を測定し、
この時の温度変化から下記の式によりTWL値を算出し
た。
That is, the test subject's skin surface is sealed in a measurement cell, forced dry air is vented into the cell to sufficiently replace the inside of the cell with dry air, and then the ventilation of dry air is stopped and the cell is closed at that point. Determine the relative humidity RHs (%) within the cell, then let it stand for 10 minutes and then increase the relative temperature RH inside the cell again. (%),
The TWL value was calculated from the temperature change at this time using the following formula.

SXI(J(1 但し、Dt:測定温度下(t ℃)での空気中の飽和水
蒸気の密度(mg/1) ■ :セルの容積(1) S :測定面積(cm”) +21TWL値変化率 皮膚に試料(皮膚化粧料)を塗布する以前と以後におけ
るTWL値をそれぞれ求め、その変化率を下記の式より
算出し、TWL低凍効果(水分保持機能亢進効果)を評
価した。
SXI (J (1) However, Dt: Density of saturated water vapor in air at measurement temperature (t °C) (mg/1) ■: Volume of cell (1) S: Measurement area (cm”) +21TWL value change rate The TWL values before and after applying the sample (skin cosmetic) to the skin were determined, and the rate of change was calculated using the following formula to evaluate the TWL hypofreezing effect (moisture retention function enhancement effect).

試料(皮膚化粧料)塗布以前のTWI、値 :  TW
L。
TWI before sample (skin cosmetic) application, value: TW
L.

試料(皮膚化粧料)塗布以後のTWL値 :  TWL
A(3)  角質層のターンオーバー速度測定方法螢光
色素のダンジルクロライドを白色ワセリン中に5重量%
配合した軟膏を作り、被検者の前腕部の皮膚に24時間
閉塞貼布し、角質層にダンジルクロライドを浸透結合さ
せる。その後同じ部位に1日2回(朝・夕)被検試料を
塗布し、毎日ダンジルクロライドの螢光をしらべ、その
螢光が消滅するまでの日数を皮膚角質層のターンオーバ
ー速度とした。なお、通常の皮膚角質層のターンオーバ
ー速度は14〜16日であるが、老化した皮膚において
は18日前後にのびる。それに対して老化防止効果が現
れると12日前後にまで短縮される。
TWL value after application of sample (skin cosmetic): TWL
A (3) Method for measuring the turnover rate of the stratum corneum 5% by weight of the fluorescent dye danzyl chloride in white petrolatum
A blended ointment is prepared and applied as an occlusive patch to the skin of the subject's forearm for 24 hours to allow danzyl chloride to penetrate and bind to the stratum corneum. Thereafter, the test sample was applied to the same area twice a day (morning and evening), and the fluorescence of danzyl chloride was checked every day.The number of days until the fluorescence disappeared was defined as the turnover rate of the skin stratum corneum. Note that the normal turnover rate of the stratum corneum of the skin is 14 to 16 days, but in aged skin, the turnover rate increases to around 18 days. On the other hand, if the anti-aging effect appears, the time will be shortened to around 12 days.

(4)  角質細胞の剥離特性 皮膚にスコッチテープにチバンメンディングテープ)を
貼付し、これを剥離して皮表の角質細胞をテープに付着
せしめた0次にこの角質細胞の状態を走査型電子顕微鏡
によって詳細に観察し、第1表に示す判定基準に基づい
て、角質細胞の剥離特性を分類してその指数を求めた。
(4) Peeling characteristics of keratinocytes A Scotch tape or Chiban mending tape) was applied to the skin, and this was peeled off to allow the keratinocytes on the skin surface to adhere to the tape.The state of the keratinocytes was then measured using scanning electronics. After detailed observation using a microscope, the exfoliation characteristics of the corneocytes were classified based on the criteria shown in Table 1, and their indices were determined.

第1表  角質細胞の剥離特性判定基準なお、この角質
細胞の剥離特性は、角質層の構造特性を判断する指標と
なるものであって、一般に乾燥皮膚、老化皮膚に於ては
、細胞間結合力か弱く、またその構造の緻密性も低いこ
とがら指数が高くなることが確認されている。
Table 1 Criteria for Judging the Peeling Properties of Corneocytes The peeling properties of corneocytes serve as an index for determining the structural properties of the stratum corneum, and in general, in dry skin and aging skin, intercellular bonds are It has been confirmed that the index is high because the force is weak and the density of the structure is also low.

実施例1〜3、比較例1 (スキンクリーム)(1) 
Mi成 原料組成    配合量(wt%) A)第2表に示す成分  第2表に示す射寺IB)流動
パラフィン        15.0ミツロウ    
         5.0ステアリン酸       
   3.0ソルビタンセスキオルエート   2.0
セタノール           2. OP、○、E
ソルビタンモノオルエート (20E、 O,) 5.O C)グリセリン          5.0バラオキシ
安息香酸メチル    0.1コハク酸モノナトリウム
塩    0.5精製水        全量をl O
0wt%とする量 第  2  表 (2)調製法 C)成分を80℃に加熱溶解した中へA)成分を均一に
分散し、これに80℃に加熱溶解したB)成分を投入し
撹拌しつつ30℃まで冷却して各スキンクリームを調製
した。
Examples 1 to 3, Comparative Example 1 (Skin Cream) (1)
Mi raw material composition Blend amount (wt%) A) Ingredients shown in Table 2 Shooter IB shown in Table 2) Liquid paraffin 15.0 Beeswax
5.0 stearic acid
3.0 Sorbitan Sesquioleate 2.0
Setanol 2. OP,○,E
Sorbitan monooleate (20E, O,) 5. O C) Glycerin 5.0 Methyl oxybenzoate 0.1 Monosodium succinate 0.5 Purified water Total volume 1 O
Amount to make 0wt% Table 2 (2) Preparation method Component A) is uniformly dispersed in a mixture of component C) heated and dissolved at 80°C, and component B) heated and dissolved at 80°C is added thereto and stirred. Each skin cream was prepared by cooling the mixture to 30°C.

(3)試験結果 試験例1 実施例1〜3の本発明のスキンクリーム及び比較例1の
スキンクリームを適用した際の、それらのTWL値及び
角質細胞剥離特性に及ぼす影響を調べた。
(3) Test Results Test Example 1 When the skin creams of the present invention of Examples 1 to 3 and the skin cream of Comparative Example 1 were applied, their effects on TWL values and keratin cell exfoliation properties were investigated.

+11  試験方法 60名の健常な普通の皮膚の被試験者(年令20〜25
才の女性)を20名ずつ、3グループ(A、C及びEグ
ループ)に、また60名の通常の乾燥皮膚を示す被試験
者(年令20〜25才の女性)を20名ずつ、3グルー
プ(B、D及びFグループ)に分けた。
+11 Test method 60 healthy normal skin test subjects (age 20-25)
20 subjects (20 to 25 years old) were divided into 3 groups (groups A, C, and E), and 60 subjects (20 to 25 years old) with normal dry skin were divided into 3 groups (groups A, C, and E). Divided into groups (B, D and F groups).

試験に先立ち全被試験者の左右前腕部皮表のT W L
(aを測定し、各グループ毎に平均値を算出した。次に
、被試験者の前腕部皮表に、左前腕には全被試験者につ
いて比較例1のスキンクリームを、また右前腕には1.
各グループ毎にA及びBグループでは実施例1.C及び
Dグループでは実施例2、E及びFグループでは実施例
3の各スキンクリームを、1日2回(朝、夕)連Vtl
カ月塗布し、最P:塗布日の翌日、全被試験者について
クリームを塗布した左右前腕部皮表部分のTWL値を測
定し、さらに角質細胞剥離特性を評価した。
Prior to the test, T W L of the skin surface of the left and right forearms of all test subjects.
(a was measured, and the average value was calculated for each group.Next, the skin cream of Comparative Example 1 was applied to the skin surface of the test subject's forearm, the left forearm for all test subjects, and the skin cream of Comparative Example 1 was applied to the right forearm. is 1.
For each group, Example 1 was used for groups A and B. Groups C and D received the skin cream of Example 2, and groups E and F received the skin cream of Example 3 twice a day (morning and evening).
The cream was applied for a month, and on the next day of application, the TWL values of the skin surface areas of the left and right forearms to which the cream had been applied were measured for all test subjects, and the keratin cell exfoliation properties were evaluated.

尚、塗布試験終了後、医師により診断した結果では、全
被試験者の前腕部の皮膚及び体調に何ら異常は認められ
なかった。
After the application test, a doctor diagnosed no abnormalities in the skin or physical condition of the forearm of any of the test subjects.

(2)   結  果 スキンクリーム塗布前及び塗布後のTWL値それらTW
L値から求めたTWL値変化率並びに角質細胞剥離特性
の指数(何れの値も各グループ20名の平均値)を第3
表に示した。
(2) Results: TWL values before and after application of skin cream.
The TWL value change rate calculated from the L value and the index of keratinocyte exfoliation characteristics (both values are the average values of 20 people in each group) were
Shown in the table.

第3表に示す結果より、下記の通り本発明の実施例1.
2及び3のスキンクリームの効果が認められた。
From the results shown in Table 3, Example 1 of the present invention is as follows.
The effects of skin creams 2 and 3 were observed.

■ A、C及びEグループの健常なfilの皮膚に於て
は、元々皮膚の水分保持機能が正常な状態に保持されて
いるので、本発明のスキンクリーム(実施例1.2及び
3)塗布の効果は顕在化しにくい状況にあるが、それで
も、比較例1に比して若干の改善が認められる。
■ In the skin of healthy fil in Groups A, C, and E, the moisture retention function of the skin is originally maintained in a normal state, so the skin cream of the present invention (Examples 1.2 and 3) was applied. Although the effect is difficult to become apparent, a slight improvement is still observed compared to Comparative Example 1.

■ B、D及びFグループの乾燥皮膚に於ては、本発明
のスキンクリーム(実施例1.2及び3)を塗布した右
前腕部皮表に、左前腕部皮表(比較例1のスキンクリー
ム)に比してTWL値の著しい改善が認められ、その値
は健常皮膚と同等か、もしくはそれに近づいている。本
発明のクリーム間の比較を行った場合、実施例3におい
て、水分保持機能改善効果が最も高く、次いで、実施例
2゜1の順であった。さらに、角質細胞剥離試験につい
ても同様な結果を得た。
■ For dry skin in Groups B, D, and F, the skin surface of the right forearm to which the skin cream of the present invention (Examples 1.2 and 3) was applied was applied, and the skin surface of the left forearm (skin of Comparative Example 1) was applied. A significant improvement in the TWL value was observed compared to the cream), and the value was equal to or approaching that of healthy skin. When comparing the creams of the present invention, Example 3 had the highest moisture retention function improvement effect, followed by Example 2.1. Furthermore, similar results were obtained in the corneum cell peeling test.

常な皮膚を保持する効果を示し、また、B、D及びeF
グループにおいては健常な皮膚に近付ける効果を有する
ことは明らかである。
It shows the effect of maintaining normal skin, and also has B, D and eF
It is clear that this group has the effect of resembling healthy skin.

これらの結果より、本発明の実施例1.2及び3のスキ
ンクリームに含まれる遠赤外放射性のセラミックスとコ
ハク酸の塩が、表皮細胞に有効に作用し、角質層の細胞
間結合能力を改善して、その構造を緻密にし、皮膚の水
分保持機能を亢進すること、及び健常な皮膚の生理機能
はこれを何ら阻害しない安全性の高いものであることが
わかる。
From these results, the far-infrared emitting ceramics and succinic acid salt contained in the skin creams of Examples 1.2 and 3 of the present invention effectively act on epidermal cells and increase the intercellular bonding ability of the stratum corneum. It can be seen that it improves the skin's structure, densifies it, and enhances the skin's moisture retention function, and that it is highly safe and does not interfere with the physiological functions of healthy skin.

試験例2 実施例3の本発明のスキンクリーム及び比較例1のスキ
ンクリームについて、それらの健常な皮膚及び老化乾燥
皮膚のTWL値及び角質層ターンオーバー速度に及ぼす
影響を調べた。
Test Example 2 The effects of the skin cream of the present invention in Example 3 and the skin cream of Comparative Example 1 on the TWL value and stratum corneum turnover rate of healthy skin and aged dry skin were investigated.

+11  試験方法 新たに、Gグループとして、健常な普通の皮膚の被試験
者20名(年令20〜25才の女性)、及びHグループ
として老化による乾燥皮膚を示す被試験者20名(年令
50〜60才の女性)の計40名について、予め左右前
腕部皮表のTWL値を測定した後、左右前腕部にダンジ
ルクロライド含有軟膏を24時間閉塞貼布した。次に、
G及びHグループの全被試験者の左前腕部皮表に比較例
1のスキンクリームを、また右前腕部皮表には実施例1
の′スキンクリームを各々1日2回(朝、夕)連!1カ
月塗布し、毎日、その螢光を調べた。最終塗布口の翌日
、全被試験者について、クリームを塗布した左右前腕部
皮表部分のTWL値を測定した。
+11 Test method Newly, 20 subjects with normal healthy skin (women aged 20 to 25 years old) were added to the G group, and 20 subjects with dry skin due to aging were added to the H group (females aged 20 to 25 years old). For a total of 40 women (50 to 60 years old), the TWL values on the skin surface of the left and right forearms were measured in advance, and ointment containing danzyl chloride was applied as an occluded patch on the left and right forearms for 24 hours. next,
The skin cream of Comparative Example 1 was applied to the skin surface of the left forearm of all subjects in Groups G and H, and the skin cream of Example 1 was applied to the skin surface of the right forearm.
'skin cream twice a day (morning and evening)! The solution was applied for one month and the fluorescence was checked every day. On the day after the final application, the TWL values of the skin surface areas of the left and right forearms to which the cream was applied were measured for all test subjects.

尚、塗布試験終了後、医師による診断結果では、全被試
験者の前腕部の皮膚及び体調に何ら異常は認められなか
った。
After the completion of the application test, no abnormality was observed in the skin of the forearm or physical condition of all the test subjects according to the results of diagnosis by a doctor.

(2)   結  果 スキンクリーム塗布前及び塗布後のTWL値(各グルー
プ20名の平均値)、それらTWL値から求めたTWL
値変化率並びに角質層ターンオーバー速度(各グループ
20名の平均値)を第4表に示した。
(2) Results TWL values before and after skin cream application (average value of 20 people in each group), TWL calculated from these TWL values
Table 4 shows the value change rate and the stratum corneum turnover rate (average values for 20 people in each group).

第4表に示す結果より、下記の通り本発明の実施例3の
スキンクリームの効果が認められた。
From the results shown in Table 4, the effects of the skin cream of Example 3 of the present invention were recognized as follows.

■ Gグループの健常な昔通の皮膚に於ては、皮膚の機
能状況が、正常に保持されていることから、本発明のス
キンクリーム(実施例3)により角質層ターンオーバー
速度の亢進は認められなかった。
■ In the healthy, conventional skin of the G group, the functional status of the skin was maintained normally, so the skin cream of the present invention (Example 3) did not increase the turnover rate of the stratum corneum. I couldn't.

また、T W 111Mについては、試験例1と同様な
結果を得た。
Further, for T W 111M, the same results as in Test Example 1 were obtained.

■ Hグループの老化乾燥皮膚に於ては、本発明のスキ
ンクリーム(実施例3)を塗布した右前腕部皮表に、左
前腕部皮表(比較例1のスキンクリーム塗布)に比べて
、角質層ターンオーバー速度の冗+!!(短縮化)が認
められ、その値は正常皮膚の値に近付くものであった。
■ In the aging dry skin of group H, the skin surface of the right forearm to which the skin cream of the present invention (Example 3) was applied was compared to the skin surface of the left forearm (to which the skin cream of Comparative Example 1 was applied). The turnover rate of the stratum corneum is ridiculous! ! (shortening) was observed, and the value approached that of normal skin.

TWL値については、試験例Iの通常の乾燥皮膚で認め
られたと同様に本発明のクリーム(実施例3)塗布によ
り、著しい改善(TWL値の低下)を示し、正常人の値
と同等か、もしくは、その値に近付くものである。
Regarding the TWL value, application of the cream of the present invention (Example 3) showed a significant improvement (reduction in the TWL value), similar to what was observed in normal dry skin in Test Example I, and it was found that the value was equivalent to that of a normal person. Or something close to that value.

即ち、本発明の実施例1のスキンクリームは、老化乾燥
皮膚の角質層ターンオーバー速度を健常な皮膚のものに
近付け、且つ、水分保持機能を高めるものと言える。
That is, it can be said that the skin cream of Example 1 of the present invention brings the turnover rate of the stratum corneum of aged dry skin closer to that of healthy skin, and enhances the water retention function.

試験例3 1ヒ較例[及び実施例1〜3のスキンクリームを乾燥皮
膚を訴える被試験者各々30名(26〜34才の女性)
に1日2回(朝、夕)連続1力月間塗布した。医師によ
る診断の結果では、全被試験者の皮膚及び体調に異常は
認められなかった。
Test Example 3 1 Comparative Example [and 30 test subjects (women aged 26 to 34 years old) who complained of dry skin when using the skin creams of Examples 1 to 3]
It was applied twice a day (morning and evening) for a continuous month. Diagnosis by a doctor revealed no abnormalities in the skin or physical condition of all test subjects.

クリームを塗布した後の皮膚に湿潤性(しっとり感)、
柔軟性(滑らか感)、弾力性及び艶を与える効果を全被
試験者について調査した結果を第5表に示した。
Moisture (moist feeling) on the skin after applying the cream,
Table 5 shows the results of a survey on all test subjects regarding the effect of imparting flexibility (smooth feel), elasticity, and gloss.

例1〜3のスキンクリームは比較的lのスキンクリーム
に比べて顕著に優れた効果を有する。
The skin creams of Examples 1 to 3 have significantly better effects than the skin creams of Examples 1 to 3.

第 表 実施例4〜5、比較例2 (スキンミルク) (1)組成 原料組成      配合量(wt%)A)ジルコン 
             2.OB)流動パラフィン
         10.0セタノール       
      2.0コレステリン          
  1.0ソルビタンモノオルニー1−     0.
5C)ソジウムセチルサルフェート    0.8第6
表に示す成分   第6表に示すM置端製氷    全
量を100wt%とする量(2)調整法 実施例1と同様に行なう。
Table Examples 4 to 5, Comparative Example 2 (Skin milk) (1) Composition Raw material composition Amount (wt%) A) Zircon
2. OB) Liquid paraffin 10.0 cetanol
2.0 cholesterin
1.0 Sorbitan monoorny 1-0.
5C) Sodium cetyl sulfate 0.8 No. 6
Ingredients shown in Table 6 M-end ice making shown in Table 6 Amount to make the total amount 100 wt% (2) Adjustment method The same procedure as in Example 1 is carried out.

第  6  表 試験例4 比較例2および実施例4〜5のスキンミルクを乾燥皮膚
を訴える被試験者各30名(年令26〜34才の女性)
に1日2回(朝、夕)連続1力月間塗布した。医師によ
る診断の結果では、全被試験者の皮膚および体調に異常
は認められなかった。
Table 6 Test Example 4 Thirty test subjects (females aged 26 to 34) complained of dry skin after receiving the skin milks of Comparative Example 2 and Examples 4 and 5.
It was applied twice a day (morning and evening) for a continuous month. Diagnosis by a doctor revealed no abnormalities in the skin or physical condition of all test subjects.

次にスキンミルクを塗布した後の皮膚に湿潤性(しっと
り感)、柔軟性(滑らが惑)、弾力性および艶を与える
効果を全被試験者について調査し第 表 第7表の結果から明らかなように、本発明の実施例4〜
5のスキンミルクはいずれも比較例2よりもすぐれた結
果を示すが、特に実施例5のスキンミルクの場合に顕著
な皮膚改善効果が認められるつ (発明の効果) 以上記載の如く、本発明の皮膚化粧料は、皮膚が本来備
えている水分保持機能を亢進することによって、皮膚を
健常な状態に保持し或いは修復して皮膚に湿潤性、柔軟
性、弾力性及び艶を与え、優れた美肌効果を有する皮膚
化粧料を明らかに提供するものである。
Next, we investigated the effects of applying skin milk on the skin in terms of moisture (moist feeling), flexibility (smoothness), elasticity, and shine on the skin, and the results are clear from the results in Table 7. As such, Examples 4 to 4 of the present invention
All of the skin milks of Example 5 show better results than Comparative Example 2, but especially the skin milk of Example 5 has a remarkable skin improvement effect. (Effects of the Invention) As described above, the present invention Skin cosmetics maintain or repair the skin in a healthy state by enhancing the skin's inherent moisture retention function, giving the skin moisture, flexibility, elasticity, and luster, and providing excellent skin care. This clearly provides a skin cosmetic that has skin beautifying effects.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図〜第4図は各々ジルコン、コージーライト、酸化
チタン、タルクの分光赤外線放射率曲線である。 第1図 5床長 (P^) −J、−gL (、^A/?Lン
Figures 1 to 4 are spectral infrared emissivity curves of zircon, cordierite, titanium oxide, and talc, respectively. Figure 1 5 Bed length (P^) -J, -gL (,^A/?Ln

Claims (1)

【特許請求の範囲】[Claims] 1)波長6〜20μmの範囲において、同一温度の黒体
の電磁波放射量を基準としたときの電磁波放射百分率が
80%以上である遠赤外線放射性セラミックス粉体とコ
ハク酸の塩とを含有してなる皮膚化粧料。
1) Contains far-infrared emissive ceramic powder and succinic acid salt that has an electromagnetic radiation percentage of 80% or more in the wavelength range of 6 to 20 μm, based on the electromagnetic radiation amount of a black body at the same temperature. skin cosmetics.
JP21314588A 1988-08-26 1988-08-26 Skin cosmetic Pending JPH0262811A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21314588A JPH0262811A (en) 1988-08-26 1988-08-26 Skin cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21314588A JPH0262811A (en) 1988-08-26 1988-08-26 Skin cosmetic

Publications (1)

Publication Number Publication Date
JPH0262811A true JPH0262811A (en) 1990-03-02

Family

ID=16634325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21314588A Pending JPH0262811A (en) 1988-08-26 1988-08-26 Skin cosmetic

Country Status (1)

Country Link
JP (1) JPH0262811A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063628C (en) * 1996-02-26 2001-03-28 北京生命之光科技发展有限责任公司 Skin massage cream
JP2001122736A (en) * 1999-10-25 2001-05-08 World Beautech:Kk Nail cosmetic

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063628C (en) * 1996-02-26 2001-03-28 北京生命之光科技发展有限责任公司 Skin massage cream
JP2001122736A (en) * 1999-10-25 2001-05-08 World Beautech:Kk Nail cosmetic

Similar Documents

Publication Publication Date Title
CN101076313B (en) Modified powder and cosmetic using the same
CN102228421B (en) Method for preparing novel crocodile-based oily raw material of daily chemical products and application thereof
JPS61236708A (en) Cosmetic
DE112014001299T5 (en) Cosmetic composition
EP3368161B1 (en) Cosmetic composition imparting a natural complexion and a healthy-looking appearance effect
US7374783B2 (en) Powders coated with specific lipoamino acid composition and cosmetics containing the same
KR101794555B1 (en) Cosmetic composition for protecting lip comprising natural ceramide and rosa canina fruit oil
JP2008115161A (en) Cosmetics containing multi-functional composite powder
JP2013136533A (en) Anti-aging cosmetic
JPS63150209A (en) Skin cosmetic
JPS60116618A (en) Cosmetic
JP2511820B2 (en) Skin cosmetics
JPH0262811A (en) Skin cosmetic
EP4029572A1 (en) Powder surface treatment method, surface treating agent composition used therefor, and surface-treated powder
JP2003192561A (en) Skin cosmetics
JP6664883B2 (en) External composition
KR102085513B1 (en) Cosmetic composition containing extract of basil seed, and mask pack and manufacturing method of mask pack using the same
JPS63159304A (en) Skin cosmetic
JPH01143810A (en) Skin cosmetic
JPH01261315A (en) Skin cosmetic
JPS60116616A (en) Cosmetic
JPH0262812A (en) Skin cosmetic
JPH0262810A (en) Skin cosmetic
JPH0259505A (en) Skin cosmetic
JPH11292751A (en) Skin cosmetic